Preclinical improvement of a therapeutic vaccine for chronic hepatitis B (TherVacB)
- Weitere Titel
-
Präklinische Optimierung eines therapeutischen Impfstoffs für die chronische Hepatitis B (TherVacB)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Technische Universität München, Dissertation, 2020
- Schlagwort
-
Hepatitis
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der TU München
- (wann)
-
2020
- Urheber
-
Su, Jinpeng
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:bvb:91-diss-20201216-1574211-1-7
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:55 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Su, Jinpeng
- Protzer-Knolle, Ulrike
- Knolle, Percy
- Gerhard, Markus
- Universitätsbibliothek der TU München
Entstanden
- 2020
Ähnliche Objekte (12)
Development of a therapeutic vaccine against chronic Hepatitis B virus infection in a preclinical model system : Therapeutic vaccine against chronic HBV infection
Preclinical evaluation of the Helicobacter pylori molecule vacuolating cytotoxin (VacA) as a therapeutic approach for allergic airway disease
Pre-clinical evaluation and improvement of attenuated malaria sporozoite vaccine candidates
Preclinical evaluation of isothiocyanates for tumour preventive and therapeutic application
Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities
Vac
Development of a thermostable, therapeutic vaccine against chronic hepatitis B
Biochemical and Pre-clinical Evaluation of 2nd Generation HIV-1 Envelope Vaccine Components
Identification of target T cell epitopes for a therapeutic HPV16 vaccine
Identification of target T cell epitopes for a therapeutic HPV16 vaccine
Verhandlungsmaterial VAC
Vác, Dominikanerkirche
Development of a therapeutic vaccine against chronic Hepatitis B virus infection in a preclinical model system : Therapeutic vaccine against chronic HBV infection
Preclinical evaluation of the Helicobacter pylori molecule vacuolating cytotoxin (VacA) as a therapeutic approach for allergic airway disease
Pre-clinical evaluation and improvement of attenuated malaria sporozoite vaccine candidates
Preclinical evaluation of isothiocyanates for tumour preventive and therapeutic application
Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities
Vac
Development of a thermostable, therapeutic vaccine against chronic hepatitis B
Biochemical and Pre-clinical Evaluation of 2nd Generation HIV-1 Envelope Vaccine Components
Identification of target T cell epitopes for a therapeutic HPV16 vaccine
Identification of target T cell epitopes for a therapeutic HPV16 vaccine
Verhandlungsmaterial VAC
Vác, Dominikanerkirche
Development of a therapeutic vaccine against chronic Hepatitis B virus infection in a preclinical model system : Therapeutic vaccine against chronic HBV infection
Preclinical evaluation of the Helicobacter pylori molecule vacuolating cytotoxin (VacA) as a therapeutic approach for allergic airway disease
Pre-clinical evaluation and improvement of attenuated malaria sporozoite vaccine candidates
Preclinical evaluation of isothiocyanates for tumour preventive and therapeutic application
Novel therapeutic venues for glioblastoma: novel rising preclinical treatment opportunities
Vac
Development of a thermostable, therapeutic vaccine against chronic hepatitis B
Biochemical and Pre-clinical Evaluation of 2nd Generation HIV-1 Envelope Vaccine Components
Identification of target T cell epitopes for a therapeutic HPV16 vaccine
Identification of target T cell epitopes for a therapeutic HPV16 vaccine
Verhandlungsmaterial VAC